|
MRI News Service:
'AMAG Pharmaceuticals, Inc' |
|
| Result: Searchterm 'AMAG Pharmaceuticals, Inc' found in 18 news | | Result Pages | | More Results:  Database (10) |
|
|
 |
 | | | ''''AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that the company has updated the product label for Feraheme(R) (ferumoxytol) Injection for Intravenous (IV) use. This update is based on the U.S. Food and Drug Administration's approval of the ...' | | Tuesday, 21 June 2011 by ir.amagpharma.com |
|
|
|
| | | ''''AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia, today reported unaudited consolidated financial results for the fourth ...' | | | Friday, 25 February 2011 by ir.amagpharma.com | |
|
|
|
| | | ''''AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG), a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia, today reported unaudited consolidated financial results for the third ...' | | | Thursday, 28 October 2010 by ir.amagpharma.com | |
|
|
|
| | | ''''AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG), a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia and novel imaging agents to aid in the diagnosis of cancer and ...' | | | Wednesday, 28 July 2010 by www.snl.com | |
|
|
|
| | | ''''AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) and Takeda Pharmaceutical Company Limited (TSE: 4502) today provided a regulatory and clinical update for Feraheme® (ferumoxytol) Injection for intravenous (IV) use. On June 1, 2010, AMAG submitted a ...' | | | Tuesday, 29 June 2010 by www.snl.com | |
|
|
|
| | | ''''AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that management will present at the following investor conferences during the month of June: June 9, at 8:00 a.m. ET – 9th Annual Needham Healthcare Conference in New York City; June 10, at ...' | | | Friday, 4 June 2010 by www.snl.com | |
|
|
|
| | | ''''AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG), a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia and novel imaging agents to aid in the diagnosis of cancer and ...' | | | Tuesday, 27 April 2010 by www.snl.com | |
|
|
|
| | | ''''AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced it will report unaudited consolidated financial results for the quarter ended March 31, 2010 after the U.S. financial markets close on April 27, 2010. The announcement will be followed by a ...' | | | Wednesday, 21 April 2010 by www.snl.com | |
|
|
|
| | | ''''AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) and Takeda Pharmaceutical Company Limited (TSE: 4502) today jointly announced that the companies have entered into a license, development and commercialization agreement related to Feraheme(R) (ferumoxytol) ...' | | | Thursday, 1 April 2010 by www.snl.com | |
|
|
|
| | | ''''AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced it will report unaudited consolidated financial results for the fourth quarter and year ended December 31, 2009 before the U.S. financial markets open on March 1, 2010. The announcement will be ...' | | | Monday, 22 February 2010 by www.snl.com | |
|
|
|
|
|
|
|
|
| Result Pages |
|
|
|
|
|
It is absurd to divide people into good and bad. People are either charming
or tedious.
- Oscar Wilde |
|
|
News
top
